用于通过抗炎,抗氧化和微生物群调节治疗炎症性肠病的含有库尔库和糖酸的自组纳米颗粒的胰岛素水凝
Jiaxin Wu1, Leyan Wang1, Han Lu1
1The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
一种新型的黄素和糖酸水凝 (CURG@IN) 为炎症性肠病 (IBD) 提供安全有效的口服治疗方法. 它可以减少炎症,增强肠道屏障功能,恢复微生物平衡,
科学领域:
- 生物材料科学
- 胃肠病学
- 纳米技术
背景情况:
- 目前的炎症性肠病 (IBD) 治疗面临有效性和全身毒性的挑战.
- 需要创新的治疗策略来治疗IBD.
研究的目的:
- 开发和评估一个装有黄素和糖酸自组装纳米颗粒 (CURG@IN) 的胰腺炎治疗剂.
- 在体外和体内研究CURG@IN的抗炎,抗氧化和微生物群调节作用.
主要方法:
- 开发具有酶反应药物释放的CURG@IN水凝.
- 在体外评估抗氧化活性,上皮细胞保护,巨细胞极化和NF- kB通路抑制.
- 在DSS诱导的大肠炎小鼠中的体内评估,评估疾病活性,结肠组织学,肠道屏障完整性和肠道微生物群组成.
主要成果:
- 在实验室中,CURG@IN表现出强大的抗氧化和抗炎作用.
- 口服CURG@IN显著改善了结肠炎症状,并在体内恢复了结肠组织.
- 治疗增强了肠道屏障功能,促进了微生物平衡,没有明显的毒性.
结论:
- CURG@IN为IBD提出了一种多机制的口服治疗策略,结合了抗炎,抗氧化和微生物群调节的作用.
- 这种新的水凝配方在IBD治疗中具有安全和有效的临床应用.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
